project id: TCGA-BLCA; case submitter id: TCGA-G2-A2ES; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.97; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.8; age at index: 85; days to birth: -31293; days to death: 1004; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1924; age at diagnosis: 31293; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 525.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.5616438356164384; pack years smoked: 65.0; is ffpe: false; composition: Not Reported; days to collection: 694; days to sample procurement: 0; specimen type: Solid Tissue; percent monocyte infiltration: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0;